15-PGDH Inhibitor Composition With Structural Parameter Changes
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a lack of a compound with a satisfactory 15-PGDH inhibitory effect for the prevention and treatment of various medical conditions associated with 15-PGDH and its substrates.
Innovation Solution
A compound represented by the general formula (1) or its pharmacologically acceptable salts, featuring specific structural components and substituents, exhibits excellent 15-PGDH inhibitory activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing 15-PGDH inhibitors are used, then some inhibitory effect is achieved, but the inhibitory effect is not satisfactory for preventing and treating various medical conditions
Solution Approach 1:
The patent modifies the chemical structure of existing 15-PGDH inhibitors by changing specific parameters such as introducing a carbonyl group at the 1-position and varying substituents at the 3-position of the cyclopentane ring. These parameter changes result in compounds with enhanced inhibitory activity against 15-PGDH, thereby improving the reliability of the inhibitory effect for treating medical conditions associated with prostaglandin metabolism.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compound effectively inhibits 15-PGDH, offering potential therapeutic benefits for a wide range of medical conditions including fibrosis, inflammatory diseases, cardiovascular diseases, autoimmune diseases, and other disorders by modulating the activity of prostaglandins and inflammation resolving lipid mediators.
Implementation Method 1
15-PGDH inhibitor comprising, as an active ingredient, the compound represented by the general formula (1) or a pharmacologically acceptable salt thereof
Data Source
AI summary
A compound represented by general formula (1) or a pharmacologically acceptable salt thereof for inhibiting 15-PDGH.